The Prognostic Potential of <scp>circRNAs</scp> in Multiple Myeloma: Insights From Whole Bone Marrow and Purified Plasma Cells

Theresa Jakobsen(Aarhus University), Lasse S. Kristensen(Aarhus University), Morten Nørgaard Andersen(Aarhus University), Alenka Djarmila Behsen(Norwegian University of Science and Technology), Torben Plesner(University of Southern Denmark), Holger Jon Møller(Aarhus University), Kristine Misund(Norwegian University of Science and Technology), Gro Grunnet Pløen(Aarhus University), Karen Dybkær(Aalborg University Hospital)

Journal of Cellular and Molecular Medicine

November 1, 2024

10.1111/jcmm.70215

Cited by 3

Related Papers

Circular RNAs in cancer: opportunities and challenges in the field

|Oncogene|2017|1.4k

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

|Blood|2009|390

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Leukemia|2012|362